PfizerPFE

Pfizer's pipeline and vaccines pull in bioprocessing, fill-finish and lab suppliers.

View stock

Theme · Biopharma manufacturing

Where the cash goes~$24B / yr · FY2025

R&D$10.5B

Dividends$9.5B

Capex$3.5B

Money flows left → right · hover a node · click to open the stock.ManufacturingComponents

Most exposed to PFE's spend

Thermo FisherTMOCurated
Bioprocessing and CDMO services.
Manufacturing
CatalentCTLTCurated
Fill-finish capacity.
Manufacturing
DanaherDHRCurated
Filtration and bioprocessing.
Manufacturing
West PharmaceuticalWSTCurated
Injectable delivery components.
Components

Relationships are hand-curated and sourced from filings, announcements, and public reporting — a map for generating ideas, not a complete supply chain, and not investment advice. Exposure weights are relative, for sizing only. Spot something missing? Contributions welcome on GitHub.